Tempest Therapeutics (TPST) Other Working Capital Changes (2012 - 2025)
Tempest Therapeutics (TPST) posted Other Working Capital Changes of -$264000.0 for Q4 2025, down 2.33% sequentially from -$258000.0 in Q3 2025, and down 18.39% YoY from -$323472.5 in Q4 2024.
Tempest Therapeutics (TPST) Other Working Capital Changes (2012 - 2025) Analysis & Trends
Tempest Therapeutics has reported Other Working Capital Changes for 6 years, with the latest figure at -$264000.0 in Q4 2025.
- Quarterly Other Working Capital Changes fell 18.39% year-over-year to -$264000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$870000.0 (up 20.98% YoY) and the FY2025 annual result came in at -$870000.0, up 20.98% from the prior year.
- Other Working Capital Changes fell to -$264000.0 in Q4 2025 per TPST's latest filing, from -$258000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $797000.0 in Q3 2021 and troughed at -$1.3 million in Q2 2021.
- A 5-year average of -$71700.0 and a median of -$37000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes tumbled 347.27% in 2022, then jumped 71.68% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$341000.0 in 2021, then advanced by 14.66% to -$291000.0 in 2022, then sank by 33.68% to -$389000.0 in 2023, then surged by 42.67% to -$223000.0 in 2024, then slipped by 18.39% to -$264000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$264000.0, -$258000.0, and -$252000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tempest Therapeutics | 4.32 Mn | 3.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Sep 30, 2025 | -243,000.00 |
| Sep 30, 2025 | -243,000.00 |
| Sep 30, 2025 | -243,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Mar 31, 2025 | -231,000.00 |
| Mar 31, 2025 | -231,000.00 |
| Mar 31, 2025 | -231,000.00 |
| Dec 31, 2024 | 159,000.00 |
| Dec 31, 2024 | 159,000.00 |
| Dec 31, 2024 | 159,000.00 |
| Sep 30, 2024 | 660,000.00 |
| Sep 30, 2024 | 660,000.00 |
| Sep 30, 2024 | 660,000.00 |
| Jun 30, 2024 | -747,000.00 |
| Jun 30, 2024 | -747,000.00 |